# Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation

> **NCT00040001** · PHASE2 · COMPLETED · sponsor: **Aderis Pharmaceuticals**

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** DTI-0009

## Key facts

- **NCT ID:** NCT00040001
- **Lead sponsor:** Aderis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00040001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00040001, "Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00040001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*